摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(Z)-[amino(4-fluorophenyl)methylidene]amino 2-chloroacetate | 794554-75-9

中文名称
——
中文别名
——
英文名称
(Z)-[amino(4-fluorophenyl)methylidene]amino 2-chloroacetate
英文别名
[(Z)-[amino-(4-fluorophenyl)methylidene]amino] 2-chloroacetate
(Z)-[amino(4-fluorophenyl)methylidene]amino 2-chloroacetate化学式
CAS
794554-75-9
化学式
C9H8ClFN2O2
mdl
MFCD06655238
分子量
230.626
InChiKey
OBQGNNNYOWZVNZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    15
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.111
  • 拓扑面积:
    64.7
  • 氢给体数:
    1
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    新型 3,5-二取代-1,2,4-恶二唑衍生物作为碳酸酐酶抑制剂和细胞毒剂的合成、计算机模拟和体外评价
    摘要:
    在这项工作中,高效合成了新的 3,5-二取代-1,2,4-恶二唑,并评估了它们对人碳酸酐酶 (hCA) I 和 II 的抑制作用。它们中的大多数对 hCAs 比乙酰唑胺 (AAZ) 更有效。化合物10d和17d是对 hCA I 最有效的化合物,IC 50值分别为 0.68 和 0.96 µM。化合物7d、17d、10d和3d是最有效的 hCA II 抑制剂,IC 50值为 0.40、0.40、0.65 和 0.71 µM。分子对接研究表明,化合物10d和17d在 hCA I 的活性位点显示出与 Phe91 的 π-π 堆积相互作用。化合物10d和17d能够在 hCA II 的活性位点与 His94 形成 π-π 堆积相互作用,并与 Phe131 形成 π-阳离子相互作用。两种化合物的烷基氨基对 hCA II 活性位点的关键相互作用都有贡献。根据计算机数据,预测所有化合物都具有良好的口服生物
    DOI:
    10.1016/j.molstruc.2022.134699
  • 作为产物:
    描述:
    对氟苯腈盐酸羟胺 、 sodium carbonate 作用下, 以 乙醇丙酮 为溶剂, 生成 (Z)-[amino(4-fluorophenyl)methylidene]amino 2-chloroacetate
    参考文献:
    名称:
    新型 3,5-二取代-1,2,4-恶二唑衍生物作为碳酸酐酶抑制剂和细胞毒剂的合成、计算机模拟和体外评价
    摘要:
    在这项工作中,高效合成了新的 3,5-二取代-1,2,4-恶二唑,并评估了它们对人碳酸酐酶 (hCA) I 和 II 的抑制作用。它们中的大多数对 hCAs 比乙酰唑胺 (AAZ) 更有效。化合物10d和17d是对 hCA I 最有效的化合物,IC 50值分别为 0.68 和 0.96 µM。化合物7d、17d、10d和3d是最有效的 hCA II 抑制剂,IC 50值为 0.40、0.40、0.65 和 0.71 µM。分子对接研究表明,化合物10d和17d在 hCA I 的活性位点显示出与 Phe91 的 π-π 堆积相互作用。化合物10d和17d能够在 hCA II 的活性位点与 His94 形成 π-π 堆积相互作用,并与 Phe131 形成 π-阳离子相互作用。两种化合物的烷基氨基对 hCA II 活性位点的关键相互作用都有贡献。根据计算机数据,预测所有化合物都具有良好的口服生物
    DOI:
    10.1016/j.molstruc.2022.134699
点击查看最新优质反应信息

文献信息

  • Design, Synthesis, and Biological Activities of Novel 2-Cyanoacrylates Containing Oxazole, Oxadiazole, or Quinoline Moieties
    作者:Qiqi Zhao、Shaohua Liu、Yonghong Li、Qingmin Wang
    DOI:10.1021/jf803632t
    日期:2009.4.8
    A series of novel 2-cyanoacrylates containing an oxazole, oxadiazole, or quinoline moiety were designed and synthesized, and their structures were characterized by 1H NMR and elemental analysis (or high-resolution mass spectrometry). Their herbicidal activities against four weeds were evaluated, and the result indicated that some of the title compounds showed excellent herbicidal activities against
    设计并合成了一系列含有恶唑,恶二唑或喹啉部分的新型2-氰基丙烯酸酯,并通过1 H NMR和元素分析(或高分辨率质谱)对它们的结构进行了表征。评估了它们对四种杂草的除草活性,结果表明,某些标题化合物在375 g / ha剂量的芽后处理中显示出优异的对油菜和a菜杂草的除草活性。此外,大多数这些氰基丙烯酸酯表现出有趣的植物生长调节活性。
  • The discovery of a selective, high affinity A2B adenosine receptor antagonist for the potential treatment of asthma
    作者:Jeff Zablocki、Rao Kalla、Thao Perry、Venkata Palle、Vaibhav Varkhedkar、Dengming Xiao、Anthony Piscopio、Tenning Maa、Art Gimbel、Jia Hao、Nancy Chu、Kwan Leung、Dewan Zeng
    DOI:10.1016/j.bmcl.2004.11.044
    日期:2005.2
    Adenosine has been suggested to play a role in asthma, possibly via activation of A(2B) adenosine receptors on mast cells and other pulmonary cells. We describe our initial efforts to discover a xanthine based selective A(2B) AdoR antagonist that resulted in the discovery of CVT-5440, a high affinity A(2B) AdoR antagonist with good selectivity (A(2B) AdoR K-i = 50 nM, selectivity A(1) > 200: A(2A) > 200: A(3) > 167). (C) 2004 Elsevier Ltd. All rights reserved.
  • Antikinetoplastid activity of 3-aryl-5-thiocyanatomethyl-1,2,4-oxadiazoles
    作者:Denise M Cottrell、Jeffrey Capers、Manar M Salem、Kate DeLuca-Fradley、Simon L Croft、Karl A Werbovetz
    DOI:10.1016/j.bmc.2004.03.054
    日期:2004.6
    A series of 5-thiocyanatomethyl- and 5-alkyl-3-aryl-1,2,4-oxadiazoles were synthesized and evaluated for their activity against kinetoplastid parasites. Formation of the oxadiazole ring was accomplished through the reaction of benzamidoximes with acyl chlorides, while the thiocyanate group was inserted by reacting the appropriate 5-halomethyl oxadiazole with ammonium thiocyanate. The thiocyanate-containing compounds possessed low micromolar activity against Leishmania donovani and Trypanosoma brucei, while the 5-alkyl oxadiazoles were less active against these parasites. 3-(4-Chlorophenyl)-5-(thiocyanatomethyl)-1,2,4-oxadiazole (compound 4b) displayed modest selectivity for L. donovani axenic amastigote-like parasites over J774 macrophages, PC3 prostate cancer cells, and Vero cells (6.4-fold, 3.8-fold, and 9.1-fold, respectively), while 3-(3,4-dichlorophenyl)-5-(thiocyanatomethyl)-1,2,4-oxadiazole (compound 4h) showed 30-fold selectivity against Vero cells but was not selective against PC3 cells. In a murine model of visceral leishmaniasis, compound 4b decreased liver parasitemia caused by L. donovani by 48% when given in five daily i.v. doses at 5 mg/kg and by 61 % when administered orally for 5 days at 50 mg/kg. These results indicate that aromatic thiocyanates hold promise for the treatment of leishmanial infections if the selectivity of these compounds can be improved. (C) 2004 Elsevier Ltd. All rights reserved.
  • Discovery and preliminary evaluation of 2-aminobenzamide and hydroxamate derivatives containing 1,2,4-oxadiazole moiety as potent histone deacetylase inhibitors
    作者:Jin Cai、Hongtao Wei、Kwon Ho Hong、Xiaoqing Wu、Meng Cao、Xi Zong、Lushen Li、Chunlong Sun、Junqing Chen、Min Ji
    DOI:10.1016/j.ejmech.2015.04.002
    日期:2015.5
    Using Entinostat as a lead compound, 2-aminobenzamide and hydroxamate derivatives have been designed and synthesized. The entire target compounds were investigated for their in vitro anti-proliferative activities using the MTT-based assay against five human cancer cell lines including U937, A549, NCI-H661, MDA-MB-231 and HCT116. 2-Aminobenzamide series of compounds (10a-10j) demonstrated the most significant inhibition against human acute monocytic myeloid leukemia cell line U937, but no or poor activities against two human lung cancer cell lines. Furthermore, the target compounds were screened for their inhibitory activities against HDAC 1, 2, and 8. 2-Aminobenzamide derivatives (10) manifested a higher selectivity for HDAC 1 over HDAC 2, but were not active against HDAC 8. In contrast, most hydroxamate derivatives (11) inhibit HDAC 8 with lower IC50 values than SAHA and Entinostat. Docking study with selected compounds 10f and ha revealed that the compounds might bind tightly to the binding pockets in HDAC 2 and HDAC 8, respectively. The results suggest that they may be promising lead compounds for the development of novel anti-tumor drug potentially via inhibiting HDACs. (C) 2015 Elsevier Masson SAS. All rights reserved.
  • Synthesis, in silico and in vitro evaluation of new 3,5-disubstituted-1,2,4-oxadiazole derivatives as carbonic anhydrase inhibitors and cytotoxic agents
    作者:Kaan Kucukoglu、Nagihan Faydali、Dilek Bul、Hayrunnisa Nadaroglu、Belgin Sever、Mehlika Dilek Altıntop、Bahadır Ozturk、Ilkay Guzel
    DOI:10.1016/j.molstruc.2022.134699
    日期:2023.3
    In this work, new 3,5-disubstituted-1,2,4-oxadiazoles were synthesized efficiently and evaluated for their inhibitory effects on human carbonic anhydrase (hCA) I and II. Most of them were more potent on hCAs than acetazolamide (AAZ). Compounds 10d and 17d were the most potent compounds on hCA I with IC50 values of 0.68 and 0.96 µM, respectively. Compounds 7d, 17d, 10d, and 3d were the most effective
    在这项工作中,高效合成了新的 3,5-二取代-1,2,4-恶二唑,并评估了它们对人碳酸酐酶 (hCA) I 和 II 的抑制作用。它们中的大多数对 hCAs 比乙酰唑胺 (AAZ) 更有效。化合物10d和17d是对 hCA I 最有效的化合物,IC 50值分别为 0.68 和 0.96 µM。化合物7d、17d、10d和3d是最有效的 hCA II 抑制剂,IC 50值为 0.40、0.40、0.65 和 0.71 µM。分子对接研究表明,化合物10d和17d在 hCA I 的活性位点显示出与 Phe91 的 π-π 堆积相互作用。化合物10d和17d能够在 hCA II 的活性位点与 His94 形成 π-π 堆积相互作用,并与 Phe131 形成 π-阳离子相互作用。两种化合物的烷基氨基对 hCA II 活性位点的关键相互作用都有贡献。根据计算机数据,预测所有化合物都具有良好的口服生物
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐